We are live on ! Find out more

1,340 hedge funds and large institutions have $98B invested in Amgen in 2014 Q4 according to their latest regulatory filings, with 187 funds opening new positions, 448 increasing their positions, 510 reducing their positions, and 54 closing their positions.

New
Increased
Maintained
Reduced
Closed

246% more first-time investments, than exits

New positions opened: 187 | Existing positions closed: 54

32% more funds holding in top 10

Funds holding in top 10: 7599 (+24)

12% more capital invested

Capital invested by funds: $87.2B → $98B (+$10.8B)

10% more funds holding

Funds holding: 1,2221,340 (+118)

12% less repeat investments, than reductions

Existing positions increased: 448 | Existing positions reduced: 510

24% less call options, than puts

Call options by funds: $1.05B | Put options by funds: $1.38B

Holders
1,340
Holders Change
+118
Holders Change %
+9.66%
% of All Funds
35.74%
Holding in Top 10
99
Holding in Top 10 Change
+24
Holding in Top 10 Change %
+32%
% of All Funds
2.64%
New
187
Increased
448
Reduced
510
Closed
54
Calls
$1.05B
Puts
$1.38B
Net Calls
-$327M
Net Calls Change
-$308M
Name Holding Trade Value Shares
Change
Change in
Stake
Capital World Investors
151
Capital World Investors
California
$66.6M +$25.7M +165,000 +65%
CLOS
152
Compagnie Lombard Odier SCmA
Switzerland
$65.4M -$53.9M -345,675 -46%
HCM
153
Highline Capital Management
New York
$61.9M -$21.9M -140,600 -27%
Korea Investment Corp
154
Korea Investment Corp
South Korea
$61.5M -$2.43M -15,600 -4%
TCM
155
Tekla Capital Management
Massachusetts
$60.6M -$20.2M -129,763 -25%
N
156
Nuveen
North Carolina
$60.2M +$16.7M +107,388 +40%
AIG
157
American International Group
New York
$59.4M -$386K -2,480 -0.7%
Canada Pension Plan Investment Board
158
Canada Pension Plan Investment Board
Ontario, Canada
$59.2M +$21.8M +139,659 +60%
DCLA
159
Douglas C. Lane & Associates
New York
$59.1M -$661K -4,239 -1%
Caisse de Depot et Placement du Quebec (CDPQ)
160
Caisse de Depot et Placement du Quebec (CDPQ)
Quebec, Canada
$58.8M -$5.1M -32,700 -8%
BNP Paribas Asset Management
161
BNP Paribas Asset Management
France
$58.4M -$9.85M -63,238 -15%
SC
162
Stralem & Co
New York
$58M -$23.1M -147,999 -29%
THSP
163
Taube Hodson Stonex Partners
United Kingdom
$57.3M -$2.25M -14,467 -4%
CCMH
164
Cornerstone Capital Management Holdings
New York
$56.8M +$17.4M +111,600 +46%
ACI
165
AMP Capital Investors
Australia
$56.8M -$20.7M -133,062 -27%
QI
166
QS Investors
New York
$56.3M +$47.2M +303,206 +607%
JIM
167
Jupiter Investment Management
United Kingdom
$55.7M +$54.5M +349,576 New
Public Employees Retirement Association of Colorado
168
Public Employees Retirement Association of Colorado
Colorado
$55.3M +$7.92M +50,797 +17%
DIA
169
Dana Investment Advisors
Wisconsin
$55.2M +$21.3M +136,456 +65%
M&T Bank
170
M&T Bank
New York
$54.2M +$1.59M +10,215 +3%
SAM
171
Sentinel Asset Management
Vermont
$54.2M -$1.23M -7,900 -2%
SCM
172
Smead Capital Management
Arizona
$53.7M -$4.76M -30,545 -8%
JMPWA
173
JP Morgan Private Wealth Advisors
California
$53M +$1.51M +9,696 +3%
SAM
174
Sawgrass Asset Management
Florida
$52.4M +$7.24M +46,481 +16%
FQ
175
First Quadrant
California
$51.9M +$21.5M +137,700 +73%

AMGN Hedge Fund Activity: Q4 2014 in Review

1,340 of the 3,749 institutional investors tracked by Wall St. Rank reported a position in Amgen (AMGN) for Q4 2014, worth a combined $98B — up 12% from $87.2B a quarter earlier.

Buyers outnumbered sellers: 187 funds opened new AMGN positions and 54 closed out — a net gain of 133 holders — while 448 added to existing stakes and 510 trimmed.

The largest buyer was Third Point, adding an estimated $1.46B. The largest seller was Americafirst Capital Management, exiting entirely with an estimated $766M sold.

  • 1,340 institutional investors held Amgen (AMGN) as of Q4 2014, up from 1,222 in Q3 2014.
  • Funds reported $98B of Amgen stock for Q4 2014, up 12% quarter-over-quarter.
  • 187 funds opened new Amgen positions in Q4 2014 and 54 closed out, a net change of +133 holders.
  • The largest Amgen buyer in Q4 2014 was Third Point, an estimated $1.46B added.
  • The largest Amgen seller in Q4 2014 was Americafirst Capital Management, an estimated $766M sold.

Based on aggregated 13F filings for Q4 2014.